Suppression of the immune response by alpha-fetoprotein on the primary and secondary antibody response.
Open Access
- 1 February 1975
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 141 (2), 269-286
- https://doi.org/10.1084/jem.141.2.269
Abstract
Mouse amniotic fluid was shown to contain a noncytotoxic inhibitor of primary gammaM and secondary gammaM, gammaG subclass splenic plaque forming cells in vitro to SRBC. The suppressive effect was not abolished by exhaustive dialysis or by absorption of mouse amniotic fluid (MAF) with SRBC. Polyacrylamide gel analysis showed that dialyzed MAF was composed of three major protein components, transferrin, albumin, and alpha-fetoprotein (AFP). The selective removal of each of these patients from MAF by affinity chromatography suggested that AFP was the immunosuppressive substance in MAF. This conclusion was verified by the demonstration that pure AFP suppressed in vitro antibody synthesis in microgram quantities whereas equivalent amounts of normal mouse serum, transferrin, or albumin did not. Dose-response studies showed that the effect of AFP in the isolated form was equivalent to the suppressive effect of comparable amounts of AFP in MAF. gammaA and gammaG plaque-forming cell (PFC) responses were suppressed by a significantly lower concentration of AFP than was the gammaM PFC response. The degree of suppression watration of AFP than was the gammaM PFC response. The degree of suppression was dependent on the time at which AFP was added to the cultures; MAF added to antigen-stimulated cultures up to 24 h after initiation of cultures was immunosuppressive whereas similar additions of MAF at 48 h after initiation or later did not suppress. The duration of exposure of spleen cells to MAF in cultures without antigen necessary to achieve suppression of a subsequent primary immune response was determine-d to be approximately 8 h. The results suggest that AFP may have an immunoregulatry function. This has potentially important implications in the maternal-fetal relationship, the immune capabilities of the fetus and newborn, and in certain malignant and nonmalignant diseases in which AFP is elevated.Keywords
This publication has 52 references indexed in Scilit:
- Alpha‐fetoprotein: Immunochemical Purification and Chemical Properties. Expression in Normal State and in Malignant and non‐Malignant Liver DiseaseImmunological Reviews, 1974
- Amniotic fluid proteins: Maternal and fetal contributionsThe Journal of Pediatrics, 1974
- Intrinsic alteration of lymphocyte reactivity in women with normal pregnancy or tumor of placental originCellular Immunology, 1974
- SERUM-ALPHA-FETOPROTEIN LEVELS IN PATIENTS WITH ATAXIA-TELANGIECTASIAThe Lancet, 1972
- IMMUNOSURVEILLANCE AND CANCERThe Lancet, 1970
- TOLERANCE AND IMMUNITY TO MATERNALLY DERIVED INCOMPATIBLE IgG2a-GLOBULIN IN MICEThe Journal of Experimental Medicine, 1970
- Abrogation of Cellular Immunity to Antigenically Foreign Mouse Embryonic Cells by a Serum FactorNature, 1969
- DISC ELECTROPHORESIS – II METHOD AND APPLICATION TO HUMAN SERUM PROTEINS*Annals of the New York Academy of Sciences, 1964
- DISC ELECTROPHORESIS‐I BACKGROUND AND THEORY*Annals of the New York Academy of Sciences, 1964
- THE EFFECTS OF ADRENOCORTICAL HORMONES, ADRENOCORTICOTROPHIC HORMONE AND PREGNANCY ON SKIN TRANSPLANTATION IMMUNITY IN MICEJournal of Endocrinology, 1956